Showing all 4 results
Chlordiazepoxide Hydrochloride Tablets
FreeProduct Composition & Strength
We supply this product as Sugar Coated Tablets (often Green or Yellow). The robust coating is essential to mask the intensely bitter taste of the API and protect the light-sensitive drug.
Active Ingredient Strength (Standard) Therapeutic Role Chlordiazepoxide HCl USP/BP 10 mg Mild Anxiety / Elderly / Taper End Chlordiazepoxide HCl USP/BP 25 mg Severe Anxiety / Alcohol Detox Loading Excipients Q.S. Sucrose / Talc / Calcium Carbonate Sugar Coating (Light Barrier) Clonazepam Tablets
FreeProduct Composition & Available Strengths
We supply Clonazepam across the complete, internationally standardized therapeutic spectrum to facilitate precise titration for both pediatric epilepsy and high-potency adult neurological control.
Active Ingredient Monograph Available Strengths Formulation Matrix Delivery System Primary Clinical Application Clonazepam USP / BP / IP 0.5 mg
(500 mcg)
Oral / Sublingual Micro-Tablet Epilepsy Titration / Panic Baseline: For pediatric seizure disorders, low-dose stabilization, and initial panic management. Clonazepam USP / BP / IP 1.0 mg
(1000 mcg)
Oral / Sublingual Micro-Tablet Intermediate Maintenance: Step-up strength optimized for routine daily neurological maintenance without expanding tablet counts. Clonazepam USP / BP / IP 2.0 mg
(2000 mcg)
Oral High-Potency Solid Tablet Refractory Epilepsy & Acute Care: High-strength configuration calibrated for status epilepticus prophylaxis, myoclonic spasms, and manic stabilization. Escitalopram Oxalate & Clonazepam Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, High-Density Microdose FDC Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips to ensure the absolute chemical stability of both active pharmaceutical ingredients.
Active Ingredient Strength Primary Clinical Function Escitalopram (as Oxalate) USP/Ph.Eur. 5 mg / 10 mg The Serotonin Anchor (Macro-Dose): The foundational, highly selective SSRI required to cure the underlying clinical depression and generalized anxiety. Clonazepam USP/Ph.Eur. 0.25 mg / 0.5 mg The Anxiolytic Bridge (Micro-Dose): The highly potent, long-acting benzodiazepine required to suppress acute panic attacks and SSRI-induced activation syndrome. Excipients Microcrystalline Cellulose / Croscarmellose Sodium / Povidone K-30 / Colloidal Silicon Dioxide / Magnesium Stearate / Premium Polymeric Film Diluent / Superdisintegrant / High-Shear Binder / Glidant / Film-Coating (Engineered specifically utilizing advanced multi-stage geometric dilution to ensure the lethal 0.25mg/0.5mg micro-dose of Clonazepam is flawlessly distributed throughout the Escitalopram matrix, preventing toxic “hot spots”) *Pack Sizes: 10×10 Alu-Alu Blisters (Optimized specifically for strict 2-to-4 week short-term bridging regimens before stepping down to Escitalopram monotherapy).
Lorazepam Tablet
FreeProduct Composition & Available Strengths
We supply Lorazepam across the complete, internationally standardized therapeutic spectrum to allow for safe dose titration and exact behavioral control.
Active Ingredient Monograph Available Strengths Formulation Matrix Delivery System Primary Clinical Target Lorazepam USP / BP / IP 0.5 mg Oral / Sublingual Micro-Tablet Mild Anxiety & Pediatric Titration: For delicate introductory dosing and generalized anxiety management. Lorazepam USP / BP / IP 1.0 mg Oral / Sublingual Micro-Tablet Foundation Anxiolytic / Insomnia: Standard baseline dosage for acute panic control and pre-operative sedation. Lorazepam USP / BP / IP 2.0 mg Oral High-Potency Solid Tablet Critical Care Stabilization: For intensive management of acute manic states, alcohol withdrawal delirium, and status epilepticus.
